$CNK

Cinemark Holdings, Inc. Stock 12‑Month Price Target Raised to $36.92, Implies 6% Upside

Less than 1 min read According to estimates from 13 analysts, Cinemark Holdings, Inc. stock's average price target has risen from $36.31 to $36.92, with forecasts ranging from $30 to $43 per share Based on the Jul. 29 closing price, the updated target implies approximately 6% potential upside Consensus rating remains at “Buy” across 13 covering analysts, with 10 Buys, 3 Holds and 0 Sells Explore more price target data and ratings for Cinemark Holdings, Inc.

Original reporting
Published Jul 30, 2026, 10:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 3:38 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cinemark Holdings, Inc. Stock 12‑Month Price Target Raised to $36.92, Implies 6% Upside — source image
Decision brief

The 30-second read

$CNKBullishLow
01

Why it matters

For CNK, the only actionable element is the modest target increase and continued “Buy” consensus; there is no new company disclosure.

02

Market read

Street targets moved slightly higher, implying modest upside versus the referenced Jul. 29 close, but without new fundamentals.

03

What to watch

The article provides no thesis details behind the target change, so traders cannot distinguish valuation support from demand or cost assumptions.

Relevance 4/10Novelty 4/10Timing: published late July 30, after-hours

Background

The piece summarizes FactSet-based analyst consensus: average price target, range, and rating mix.

Company-level read

Ticker impact

$CNKBullishMedium confidence
Context

Cinemark’s average analyst price target rose from $36.31 to $36.92, with a consensus “Buy” rating unchanged across 13 analysts.

Expected impact

Likely limited near-term impact; any reaction should be incremental unless accompanied by new earnings or company-specific news.

Evidence & confidence

This is a consensus price-target update (FactSet/analyst estimates) rather than a disclosed company event, so it typically drives smaller, sentiment-driven moves.

Market effects

Minor read-through for cinema/theater equities sentiment, but no sector-wide new data is provided.

None indicated.

None indicated.

Counterpoint

Raised targets can reflect model recalibration rather than improved fundamentals, so downside risk remains if operating metrics disappoint.

Key entities

  • Cinemark Holdings, Inc.

    Subject of the article, with analyst price target raised to $36.92 and consensus “Buy” maintained.

Related articles

$CNKMed

Cinemark Holdings, Inc. (CNK): Results of Operations and Financial Condition

Cinemark Holdings, Inc. (CNK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cnk-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 CINEMARK HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS Generated all-time high quarterly revenue of $1.1 billion with records across all major revenue categories Delivered Net Income of $141 million, an increase of nearly

$IMAXMed

Nolan’s ’The Odyssey’ eyes $200M global debut, benefiting IMAX and theater stocks By Investing.com

Christopher Nolan’s “The Odyssey” is set to open in theaters Friday with a projected $200M worldwide debut. Variety projects $90M to $100M domestic opening across 3,900 North American theaters. IMAX (IMAX) benefits from limited IMAX 70mm capacity. AMC (AMC) got a July 15 upgrade to Buy with a $3.00 target. Marcus (MCS) and Cinemark (CNK) may also gain. IMAX Q2 2026 earnings are due July 23.

$TSCOMed

Tractor Supply downgrade, Five Below upgraded: Wall Street's top analyst calls

Wall Street analysts issued multiple rating changes across retail, software, media, telecom infrastructure, and industrials. Mizuho downgraded Tractor Supply (TSCO) to Neutral, cutting its FY26 outlook, while upgrading Five Below (FIVE) to Outperform with a $220 target. Goldman upgraded Toast (TOST) to Buy ($36), and other firms adjusted targets for Sarepta (SRPT), Cinemark (CNK), American Tower (AMT), and more.